Getting started
Injectable vs. Oral GLP-1s: How to Choose
Last clinically reviewed: October 1, 2026 by Dr. Prajeet Reddy, MD (Medical Director)

Prescription GLP-1 medicines for weight management now come two ways: as a shot under the skin, or as a pill. This guide puts the options side by side so you can talk through the choice with your prescriber. For a product-by-product walkthrough of the pills and pens, see GLP-1 pills vs injections.
What GLP-1 Medicines Do
GLP-1 medicines act like a natural gut hormone that helps you feel full sooner, stay full longer, and eat less. Tirzepatide works on a second hormone too, which can add to the effect. They work best combined with healthy eating and regular activity, and they're meant to be taken long-term; if you stop, some weight regain is common.[6]
The Injectable Options
Each is a small injection under the skin of your belly, thigh, or upper arm, which you can learn to give yourself at home.
- Semaglutide (Wegovy) — once a week. In its main study (STEP 1), people without diabetes lost about 15% of their body weight over about 16 months, compared with about 2% on placebo.[1] The dose is slowly increased over about 4 months to reduce stomach side effects.[9]
- Tirzepatide (Zepbound) — once a week. It works on two gut hormones. In its main study (SURMOUNT-1), people lost about 15% to 21% of body weight, depending on the dose, over about 17 months.[2] The dose is slowly increased over about 5 months.[11]
- Liraglutide (Saxenda) — once a day. An older option with less weight loss, about 8% in its main study (SCALE).[3] It needs a daily shot rather than a weekly one.
People with type 2 diabetes generally lose somewhat less weight on these medicines than people without diabetes.[6]
The Oral Options
- Wegovy tablets (oral semaglutide 25 mg) — one pill every day. In its study (OASIS 4), people without diabetes lost about 14% of body weight over about 15 months.[4] It's the same drug as the Wegovy shot, in pill form. It has strict rules: take it first thing in the morning on an empty stomach with no more than 4 ounces (about half a cup) of plain water, then wait at least 30 minutes before eating, drinking anything else, or taking other pills.[9][8]
- Foundayo (orforglipron) — one pill every day, taken with or without food, at any time of day, with no water limit.[10][7] That makes it the easiest to fit into daily life. In its main study (ATTAIN-1), people without diabetes lost about 11% of body weight at the highest dose over about 17 months.[5]
A separate pill, Rybelsus, contains the same drug as Wegovy tablets but is approved only for type 2 diabetes, not for weight loss — see oral Wegovy vs. Rybelsus.
Side-by-Side Comparison
| Medicine | Shot or pill? | How often | Typical weight loss | Key thing to know |
|---|---|---|---|---|
| Wegovy (semaglutide) | Shot | Once weekly | About 15% | Weekly; proven heart benefits |
| Zepbound (tirzepatide) | Shot | Once weekly | About 15–21% | Highest weight loss in studies |
| Saxenda (liraglutide) | Shot | Once daily | About 8% | Daily shot; less weight loss |
| Wegovy tablets (oral semaglutide) | Pill | Once daily | About 14% | Empty stomach, plain water, wait 30 minutes |
| Foundayo (orforglipron) | Pill | Once daily | About 11% | With or without food, any time |
These figures come from separate studies with different participants, so they can't be compared exactly. Where two medicines have been tested head to head, the result is clearer: see Wegovy vs. Zepbound.
Shot Versus Pill: What to Weigh
Convenience. A weekly shot means only 52 doses a year and nothing to remember daily. A daily pill means no needles, but you have to remember it every day. Wegovy tablets also have strict timing and food rules; Foundayo doesn't.[7]
How much weight you may lose. On average, the injectable options — especially tirzepatide — have produced the most weight loss in studies, with the oral options close behind.[2][4] These are averages: individual results vary, and no head-to-head study has directly compared the pills with the shots for weight loss.
Storage and travel. The pills don't need refrigeration. Wegovy and Zepbound are stored in the refrigerator, with a limited time allowed at room temperature. See GLP-1 storage rules.
Needles. If needles are a barrier, a pill may be a better fit. If you'd rather not think about medication every day, a weekly shot may suit you better.
Other medicines you take. Wegovy tablets have to be taken 30 minutes before your other morning pills. And if you use birth control pills, Zepbound and Foundayo can make them less reliable for a few weeks after you start and after each dose increase — see birth control during GLP-1 dose escalation.
Your routine. Be honest about what you'll actually do. A medicine with a higher average result won't help if its routine doesn't fit your mornings.
Common Side Effects (for All of These Medicines)
The most common side effects involve the stomach: nausea, diarrhea, constipation, and vomiting.[4][5] They're usually mild to moderate, tend to happen when starting or increasing the dose, and often improve over time. Starting low and increasing slowly helps reduce them. Less common but important problems include gallbladder trouble and, rarely, pancreas inflammation.[9]
Taking a pill doesn't avoid these side effects — they come from the medicine, not the needle.
Who Should Not Take These Medicines
Don't take these medicines if you or a close family member has had medullary thyroid cancer or a condition called MEN2.[9] Tell your prescriber if you're pregnant, planning a pregnancy, or breastfeeding — semaglutide should be stopped at least 2 months before a planned pregnancy; see GLP-1s and pregnancy. Always review your full health history and other medicines with your prescriber.
Questions to Ask Your Prescriber
- Which option fits my health conditions and other medicines?
- Which is covered by my insurance, and what will it cost?
- Do I prefer a weekly shot or a daily pill — and can I follow the instructions it requires?
- Which side effects should I watch for, and when should I call?
The Short Version
The weekly shots (Wegovy, Zepbound) have produced the most weight loss in studies, with the daily pills (Wegovy tablets, Foundayo) close behind. Pills mean no needles and no refrigeration, but a dose every day — with strict morning rules for Wegovy tablets and none for Foundayo. No study has compared pills and shots directly, so choose the one whose routine you'll actually keep, together with your prescriber.
Frequently asked questions
Do GLP-1 pills work as well as the injections?
On average the injections have produced somewhat more weight loss in studies — about 15% with Wegovy and 15–21% with Zepbound, versus about 14% with Wegovy tablets and about 11% with Foundayo. But these come from separate trials with different participants, and no head-to-head study has directly compared the pills with the shots for weight loss, so the numbers are a guide, not a ranking.
Which GLP-1 pill is easiest to take?
Foundayo. It's taken once a day at any time, with or without food, and with no limit on water. Wegovy tablets have strict rules: first thing in the morning on an empty stomach, with no more than 4 ounces of plain water, then a 30-minute wait before eating, drinking anything else, or taking other pills.
Is a weekly shot or a daily pill more convenient?
It depends on your routine. A weekly shot means 52 doses a year and nothing to remember day to day, but it involves a needle and refrigerated storage. A daily pill means no needles and no refrigeration, but you have to remember it every day — and with Wegovy tablets, follow the empty-stomach routine every morning.
Can I switch from a GLP-1 injection to a pill?
Often yes, with your prescriber. Wegovy injection and Wegovy tablets are the same drug, and some people move between them. Switching to a different medicine means following that medicine's own step-up schedule. Never take two GLP-1 medicines at the same time.
Sources
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — Wilding et al., NEJM 2021
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — Jastreboff et al., NEJM 2022
- Current Pharmacotherapy for Obesity — Srivastava & Apovian, Nat Rev Endocrinol 2018
- Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4) — Wharton et al., NEJM 2025
- Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment (ATTAIN-1) — Wharton et al., NEJM 2025
- Glucagon-Like Receptor Agonists and Next-Generation Incretin-Based Medications: Metabolic, Cardiovascular, and Renal Benefits — Nauck et al., Lancet 2026
- FDA Approves GLP-1 Obesity Pill Without Food or Water Restrictions — Anderer, JAMA 2026
- Clinical Pharmacokinetics of Oral Semaglutide — Overgaard et al., Clin Pharmacokinet 2021
- WEGOVY Prescribing Information (injection and tablets) — DailyMed (FDA)
- FOUNDAYO (orforglipron) Prescribing Information — DailyMed (FDA)
- Zepbound Prescribing Information — DailyMed (FDA)
This article is for education and does not replace your prescriber’s instructions or the FDA Medication Guide that comes with your medication. Clinical content reviewed by Dr. Prajeet Reddy, MD, Medical Director (Cyane Medical Group California PC).
$29/mo membership — the lowest in GLP-1 telehealth. No contracts.